Formulating a Sulfonated Antiviral Dendrimer in a Vaginal Microbicidal Gel Having Dual Mechanisms of Action

REFERENCES

• S. R. Abner, P. C. Guenthner, J. Guarner, K. A. Hancock, J. E. CumminsJr., A. Fink, G. T. Gilmore, C. Staley, A. Ward, O. Ali, S. Binderow, S. Cohen, L. A. Grohskopf, L. Paxton, C. E. Hart, and C. S. Dezzutti. (2005). A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection. J. Infect. Dis. 192:1545–1556.
   PubMed Web of Science ®Google Scholar
• E. Adriaens, and J. P. Remon. (2008). Mucosal irritation potential of personal lubricants relates to product osmolality as detected by the slug mucosal irritation assay. Sex. Transm. Dis. 35:512–516.
   PubMed Web of Science ®Google Scholar
• S. A. Ballagh, V. Brache, C. Mauck, M. M. Callahan, L. Cochon, A. Wheeless, and T. R. Moench. (2008). A phase I study of the functional performance, safety and acceptability of the BufferGel Duet. Contraception 77:130–137.
   PubMed Web of Science ®Google Scholar
• D. I. Bernstein, L. R. Stanberry, S. Sacks, N. K. Ayisi, Y. H. Gong, J. Ireland, R. J. Mumper, G. Holan, B. Matthews, T. McCarthy, and N. Bourne. (2003). Evaluations of unformulated and formulated dendrimer-based microbicide candidates in mouse and guinea pig models of genital herpes. Antimicrob. Agents Chemother. 47:3784–3788.
   PubMed Web of Science ®Google Scholar
• R. A. Cone, T. Hoen, X. Wong, R. Abusuwwa, D. J. Anderson, and T. R. Moench. (2006). Vaginal microbicides: Detecting toxicities in vivo that paradoxically increase pathogen transmission. BMC Infect. Dis. 6:90.
   PubMed Web of Science ®Google Scholar
• J. E. CumminsJr., J. Guarner, L. Flowers, P. C. Guenthner, J. Bartlett, T. Morken, L. A. Grohskopf, L. Paxton, and C. S. Dezzutti. (2007). Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture. Antimicrob. Agents Chemother. 51:1770–1779.
   PubMed Web of Science ®Google Scholar
• S. P. Dimitonova, S. T. Danova, J. P. Serkedjieva, and B. V. Bakalov. (2007). Antimicrobial activity and protective properties of vaginal lactobacilli from healthy Bulgarian women. Anaerobe 13:178–184.
   PubMed Web of Science ®Google Scholar
• G. Flemstrom, A. Hallgren, O. Nylander, L. Engstrand, E. Wilander, and A. Allen. (1999). Adherent surface mucus gel restricts diffusion of macromolecules in rat duodenum in vivo. Am. J. Physiol. 277:G375–G382.
   PubMed Web of Science ®Google Scholar
• E. Gong, B. Matthews, T. McCarthy, J. Chu, G. Holan, J. Raff, and S. Sacks. (2005). Evaluation of dendrimer SPL7013, a lead microbicide candidate against herpes simplex viruses. Antiviral Res. 68:139–146.
   PubMed Web of Science ®Google Scholar
• G. J. Howlett, A. P. Minton, and G. Rivas. (2006). Analytical ultracentrifugation for the study of protein association and assembly. Curr. Opin. Chem. Biol. 10:430–436.
   PubMed Web of Science ®Google Scholar
• Y. H. Jiang, P. Emau, J. S. Cairns, L. Flanary, W. R. Morton, T. D. McCarthy, and C. C. Tsai. (2005). SPL7013 gel as a topical microbicide for prevention of vaginal transmission of SHIV89.6p in macaques. AIDS Res. Hum. Retroviruses 21:207–213.
   PubMed Web of Science ®Google Scholar
• M. J. Joralemon, R. K. O'reilly, C. J. Hawker, and K. L. Wooley. (2005). Shell click-crosslinked (SCC) nanoparticles: A new methodology for synthesis and orthogonal functionalization. J. Am. Chem. Soc. 127:16892–16899.
   PubMed Web of Science ®Google Scholar
• C. Lackman-Smith, C. Osterling, K. Luckenbaugh, M. Mankowski, B. Snyder, G. Lewis, J. Paull, A. Profy, R. G. Ptak, R. W. BuckheitJr., K. M. Watson, J. E. CumminsJr., and B. E. Sanders-Beer. (2008). Development of a comprehensive human immunodeficiency virus type 1 screening algorithm for discovery and preclinical testing of topical microbicides. Antimicrob. Agents Chemother. 52:1768–1781.
   PubMed Web of Science ®Google Scholar
• C. Lacey. (2008). Unacceptable side effects of a hyperosmolar vaginal microbicide in a Phase I trial. Microbicides 2008 B08–B527. Abstract
   Google Scholar
• L. Liu, P. Li, and S. A. Asher. (1999). Entropic trapping of macromolecules by mesoscopic periodic voids in a polymer hydrogel. Nature 397:141–144.
   PubMed Web of Science ®Google Scholar
• D. S. MacLean-McDavitt, J. D. Robertson, and M. Jay. (2003). Monitoring the in vivo delivery of proteins from carbomer hydrogels by X-ray fluorescence. Pharm. Res. 20:435–441.
   PubMed Web of Science ®Google Scholar
• R. A. Maguire, N. Bergman, and D. M. Phillips. (2001). Comparison of microbicides for efficacy in protecting mice against vaginal challenge with herpes simplex virus type 2, cytotoxicity, antibacterial properties, and sperm immobilization. Sex. Transm. Dis. 28:259–265.
   PubMed Web of Science ®Google Scholar
• K. H. Mayer, J. Peipert, T. Fleming, A. Fullem, T. Moench, S. Cu-Uvin, M. Bentley, M. Chesney, and Z. Rosenberg. (2001). Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States. Clin. Infect. Dis. 32:476–482.
   PubMed Web of Science ®Google Scholar
• T. D. McCarthy, P. Karellas, S. A. Henderson, M. Giannis, D. F. O'Keefe, G. Heery, J. R. Paull, B. R. Matthews, and G. Holan. (2005). Dendrimers as drugs: Discovery and preclinical and clinical development of dendrimer-based microbicides for HIV and STI prevention. Mol. Pharm. 2:312–318.
   PubMed Web of Science ®Google Scholar
• V. M. Ndesendo, V. Pillay, Y. E. Choonara, E. Buchmann, D. N. Bayever, and L. C. Meyer. (2008). A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections. AAPS PharmSciTech. 9:505–520.
   PubMed Web of Science ®Google Scholar
• A. R. Neurath, N. Strick, and Y. Y. Li. (2002). Anti-HIV-1 activity of anionic polymers: A comparative study of candidate microbicides. BMC Infect. Dis. 2:27.
   PubMed Web of Science ®Google Scholar
• S. S. Olmsted, N. H. Dubin, R. A. Cone, and T. R. Moench. (2000). The rate at which human sperm are immobilized and killed by mild acidity. Fertil Steril 73:687–693.
   PubMed Web of Science ®Google Scholar
• S. S. Olmsted, K. V. Khanna, E. M. Ng, S. T. Whitten, O. N. JohnsonIII, R. B. Markham, R. A. Cone, and T. R. Moench. (2005). Low pH immobilizes and kills human leukocytes and prevents transmission of cell-associated HIV in a mouse model. BMC Infect. Dis. 5:79.
   PubMedGoogle Scholar
• S. S. Olmsted, J. L. Padgett, A. I. Yudin, K. J. Whaley, T. R. Moench, and R. A. Cone. (2001). Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys. J. 81:1930–1937.
   PubMed Web of Science ®Google Scholar
• D. L. Patton, Y. C. Sweeney, P. K. Cummings, L. Meyn, L. K. Rabe, and S. L. Hillier. (2004). Safety and efficacy evaluations for vaginal and rectal use of BufferGel in the macaque model. Sex. Transm. Dis. 31:290–296.
   PubMed Web of Science ®Google Scholar
• S. Roth, M. Monsour, A. Dowland, P. C. Guenthner, K. Hancock, C. Y. Ou, and C. S. Dezzutti. (2007). Effect of topical microbicides on infectious human immunodeficiency virus type 1 binding to epithelial cells. Antimicrob. Agents Chemother. 51:1972–1978.
   PubMed Web of Science ®Google Scholar
• R. Rupp, S. L. Rosenthal, and L. R. Stanberry. (2007). VivaGel (SPL7013 Gel): A candidate dendrimer–microbicide for the prevention of HIV and HSV infection. Int. J. Nanomedicine 2:561–566.
   PubMed Web of Science ®Google Scholar
• D. Tien, R. L. Schnaare, F. Kang, G. Cohl, T. J. McCormick, T. M. Moench, G. Doncel, K. Watson, R. W. BuckheitJr., M. G. Lewis, J. Schwartz, K. Douville, and J. W. Romano. (2005). In vitro and in vivo characterisation of a potential universal placebo designed for use in vaginal microbicide clinical trials. AIDS Res. Human Retroviruses 21 (10):845–853.
   PubMed Web of Science ®Google Scholar
• J. A. Turpin. (2002). Considerations and development of topical microbicides to inhibit the sexual transmission of HIV. Expert Opin. Investig. Drugs 11:1077–1097.
   PubMed Web of Science ®Google Scholar
• J. Van De Wijgert, A. Fullem, C. Kelly, S. Mehendale, S. Rugpao, N. Kumwenda, Z. Chirenje, S. Joshi, T. Taha, N. Padian, R. Bollinger, and K. Nelson. (2001). Phase 1 trial of the topical microbicide BufferGel: Safety results from four international sites. J. Acquir. Immune Defic. Syndr. 26:21–27.
   PubMed Web of Science ®Google Scholar
• D. L. Williams, D. R. Newman, S. A. Ballagh, M. D. Creinin, K. Barnhart, D. H. Weiner, A. J. Bell, and D. J. Jamieson. (2007). Phase I safety trial of two vaginal microbicide gels (Acidform or BufferGel) used with a diaphragm compared to KY jelly used with a diaphragm. Sex. Transm. Dis. 34:977–984.
   PubMed Web of Science ®Google Scholar
• L. Zeitlin, T. E. Hoen, S. L. Achilles, T. A. Hegarty, A. E. Jerse, J. W. Kreider, S. S. Olmsted, K. J. Whaley, R. A. Cone, and T. R. Moench. (2001). Tests of buffergel for contraception and prevention of sexually transmitted diseases in animal models. Sex. Transm. Dis. 28:417–423.
   PubMed Web of Science ®Google Scholar